Literature DB >> 21365578

The role of anorexia nervosa in secondary osteoporosis development with the risk for low energy fractures.

Wanda Horst-Sikorska1, Magdalena Ignaszak-Szczepaniak.   

Abstract

Anorexia nervosa (AN) has in recent years become considerably more common. The disease primarily affects girls and young women, and also boys and young men. AN is a risk factor for secondary osteoporosis. AN-related metabolic disturbances lead to diminished bone quality and increased risk of fractures. The consequences of low energy fractures are the main causes of death in women with AN. Hormonal disturbances (e.g. hypoestrogenism, increased levels of ghrelin and Y peptide, changes in leptin and endocannabinoid levels), as well as the mechanisms involved in bone resorption (RANK/RANKL/OPG), are considered to be of great importance for anorectic bone quality. The risk of osteoporotic, non-vertebral fractures in AN patients is significantly higher than in healthy women. An improvement of bone mineral density is possible after substantial body mass increase. Weight loss, in conjunction with a well-balanced, controlled diet, is the key to correct peak bone mass levels, and diminishes the risk of osteoporosis with its consequence of low energy bone fractures. (Pol J Endocrinol 2011; 62 (1): 45-47).

Entities:  

Mesh:

Year:  2011        PMID: 21365578

Source DB:  PubMed          Journal:  Endokrynol Pol        ISSN: 0423-104X            Impact factor:   1.582


  3 in total

1.  Follow-up of bone mineral density and body composition in adolescents with restrictive anorexia nervosa: role of dual-energy X-ray absorptiometry.

Authors:  E Franzoni; F Ciccarese; E Di Pietro; G Facchini; F Moscano; L Iero; A Monaldi; G Battista; A Bazzocchi
Journal:  Eur J Clin Nutr       Date:  2013-12-18       Impact factor: 4.016

2.  Seven years' experience with etidronate in a woman with anorexia nervosa and vertebral fractures.

Authors:  Jun Iwamoto; Yoshihiro Sato; Mitsuyoshi Uzawa; Tsuyoshi Takeda; Hideo Matsumoto
Journal:  Ther Clin Risk Manag       Date:  2011-07-05       Impact factor: 2.423

3.  Bone mineral density in women with polycystic ovary syndrome.

Authors:  K Katulski; S Slawek; A Czyzyk; A Podfigurna-Stopa; K Paczkowska; N Ignaszak; N Podkowa; B Meczekalski
Journal:  J Endocrinol Invest       Date:  2014-09-23       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.